Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
23.5
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2024年6月1日〜2024年8月31日ConsolidatedJapanese GAAPNet Sales1,358¥ millionYear on year +23.5%Progress 21.2%
Operating profit-3¥ million
Ordinary income-3¥ million
Net income attributable to owners of the parent-35¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share△3.92円
Financial position at period-end
Total assets3,886¥ million
of which net assets 1,874 ¥ millionEquity ratio 47.4%vs. prior year-end -0.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueMedia and Platform Business ¥288,420 thousand (YoY +13.6%), Healthcare Institution Management Support Business ¥947,860 thousand (YoY +14.9%), Medical B2B Business ¥36,521 thousand (YoY +83.9%), Cloud Integration Business ¥77,767 thousand, Pre-symptomatic disease and prevention platform business ¥6,953 thousand, Other ¥863 thousand (YoY -4.7%)
Segment profitMedia and Platform Business ¥158,337 thousand (YoY +18.7%), Healthcare Institution Management Support Business ¥18,190 thousand (YoY -3.2%), Medical B2B Business ¥-8,426 thousand, Cloud Integration Business ¥3,744 thousand, Pre-symptomatic disease and prevention platform business ¥-51,077 thousand, Other ¥863 thousand (YoY -4.7%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥6,400 million (YoY +21.9%)
Operating profit¥330 million (YoY +10.6%)
Ordinary income¥305 million (YoY -5.4%)
Profit attributable to owners of the parent¥136 million
Revision to Earnings ForecastNo revision
Annual Dividend Forecast¥3 → ¥3（0.0%）
Factors Behind Changes in Business Performance
事業拡大により売上高は増加した一方、ミルテルの収益化未実現と、事業拡大のための人員増に伴う人件費増加等により営業損失となった。
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation新規：0社（社名：なし）、除外：0社（社名：なし）
Impairment loss1,785千円（対象資産：Not disclosed）
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Impairment Losses ¥1,785 thousand, Loss on Disposal of Fixed Assets ¥214 thousand, Other ¥2,089 thousand
Depreciation and amortization¥6,683 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNone (対象者：Not applicable)
Issued Shares at Period-End10,773,000 shares
Treasury Shares at Period-End1,727,730株
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年6月1日〜2024年8月31日 |
| Net Sales | ¥1,358 million (YoY +23.5%) |
| Operating profit | ¥-3 million |
| Ordinary income | ¥-3 million |
| Profit attributable to owners of the parent | ¥-35 million |
| Net income per share | △3.92円 |
| Equity ratio | End of the current fiscal period 47.4 / End of previous period 47.8 |
| Total assets | ¥3,886 million |
| Net assets | ¥1,874 million |
| Full-year earnings forecast | Net Sales ¥6,400 million (YoY +21.9%) / Operating profit ¥330 million (YoY +10.6%) / Ordinary income ¥305 million (YoY -5.4%) / Profit attributable to owners of the parent ¥136 million |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥3 → ¥3（0.0%） |
| Segment revenue | Media and Platform Business ¥288,420 thousand (YoY +13.6%), Healthcare Institution Management Support Business ¥947,860 thousand (YoY +14.9%), Medical B2B Business ¥36,521 thousand (YoY +83.9%), Cloud Integration Business ¥77,767 thousand, Pre-symptomatic disease and prevention platform business ¥6,953 thousand, Other ¥863 thousand (YoY -4.7%) |
| Segment profit | Media and Platform Business ¥158,337 thousand (YoY +18.7%), Healthcare Institution Management Support Business ¥18,190 thousand (YoY -3.2%), Medical B2B Business ¥-8,426 thousand, Cloud Integration Business ¥3,744 thousand, Pre-symptomatic disease and prevention platform business ¥-51,077 thousand, Other ¥863 thousand (YoY -4.7%) |
| Depreciation and amortization | ¥6,683 thousand |
| Impairment loss | 1,785千円（対象資産：Not disclosed） |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Impairment Losses ¥1,785 thousand, Loss on Disposal of Fixed Assets ¥214 thousand, Other ¥2,089 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 新規：0社（社名：なし）、除外：0社（社名：なし） |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者：Not applicable) |
| Issued Shares at Period-End | 10,773,000 shares |
| Treasury Shares at Period-End | 1,727,730株 |
| Factors Behind Changes in Business Performance | 事業拡大により売上高は増加した一方、ミルテルの収益化未実現と、事業拡大のための人員増に伴う人件費増加等により営業損失となった。 |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.事業拡大により売上高は増加した。一方、2024年1月に連結子会社化した株式会社ミルテルが成長過程にあり事業の収益化が実現していないこと、事業拡大のための人員増に伴う人件費の増加等により営業損失となった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.